HEALTHSOUTH (NYSE: HLS) is expected to report Q2 earnings on July 25. Here's what Wall Street wants to see:

The 10-second takeaway
 Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict HEALTHSOUTH's revenues will expand 3.8% and EPS will grow 10.5%.

The average estimate for revenue is $553.6 million. On the bottom line, the average EPS estimate is $0.42.

Revenue details
 Last quarter, HEALTHSOUTH logged revenue of $572.6 million. GAAP reported sales were 6.2% higher than the prior-year quarter's $532.3 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 Last quarter, non-GAAP EPS came in at $0.44. GAAP EPS of $0.48 for Q1 were 23% higher than the prior-year quarter's $0.39 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
 For the preceding quarter, gross margin was 46.8%, 80 basis points better than the prior-year quarter. Operating margin was 21.3%, 150 basis points better than the prior-year quarter. Net margin was 9.1%, 80 basis points better than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $2.26 billion. The average EPS estimate is $1.75.

Investor sentiment

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on HEALTHSOUTH is outperform, with an average price target of $27.90.

Is HEALTHSOUTH the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.